Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease
Clinical trial NCT05037799 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05037799
- Sponsor
- Ottawa Heart Institute Research Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-01
- Primary completion
- 2026-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.